Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older

被引：0
|
作者：
Min Hwan Kim
Gun Min Kim
Jee Hung Kim
Jee Ye Kim
Hyung Seok Park
Seho Park
Young Up Cho
Byeong Woo Park
Seung Il Kim
Joohyuk Sohn
机构：
[1] Yonsei University College of Medicine,Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center
[2] Gangnam Severance Hospital,Division of Medical Oncology, Department of Internal Medicine
[3] Yonsei University College of Medicine,Division of Breast Surgery, Department of Surgery, Yonsei Cancer Center
[4] Yonsei University College of Medicine,undefined
来源：
Breast Cancer Research and Treatment | 2020年 / 179卷
关键词：
Intermediate HER2; Age; Prognosis; Metastatic breast cancer; Early breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：687 / 697
页数：10
相关论文
共 50 条
  • [21] Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen
    Yong Wha Moon
    Seho Park
    Joo Hyuk Sohn
    Dae Ryong Kang
    Ja Seung Koo
    Hyung Seok Park
    Hyun Cheol Chung
    Byeong-Woo Park
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1123 - 1130
  • [22] Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen
    Moon, Yong Wha
    Park, Seho
    Sohn, Joo Hyuk
    Kang, Dae Ryong
    Koo, Ja Seung
    Park, Hyung Seok
    Chung, Hyun Cheol
    Park, Byeong-Woo
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (07) : 1123 - 1130
  • [23] Increased Expression of Forkhead Box M1 Is Associated with Aggressive Phenotype and Poor Prognosis in Estrogen Receptor-Positive Breast Cancer
    Ahn, Hyein
    Sim, Jongmin
    Abdul, Rehman
    Chung, Min Sung
    Paik, Seung Sam
    Oh, Young-Ha
    Park, Chan Kum
    Jang, Kiseok
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (04) : 390 - 397
  • [24] Podoplanin expression in cancer-associated fibroblasts predicts unfavorable prognosis in node-negative breast cancer patients with hormone receptor-positive/HER2 − negative subtype
    Yuko Tanaka
    Takashi Ohno
    Taichi Kadonaga
    Yoshiteru Kidokoro
    Makoto Wakahara
    Kanae Nosaka
    Tomohiko Sakabe
    Yoshimasa Suzuki
    Hiroshige Nakamura
    Yoshihisa Umekita
    Breast Cancer, 2021, 28 : 822 - 828
  • [25] Expression of Androgen Receptor in Estrogen Receptor-positive Breast Cancer
    Agrawal, Anil
    Ziolkowski, Piotr
    Grzebieniak, Zygmunt
    Jelen, Michal
    Bobinski, Piotr
    Agrawal, Siddarth
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2016, 24 (08) : 550 - 555
  • [26] TSPAN1 overexpression as an indicator of poor prognosis in estrogen receptor-positive breast cancer
    Liu, Xiangjuan
    Zhang, Jiahong
    Zhao, Jun
    Cheng, Yan
    Jiang, Dandan
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (08)
  • [27] Elevated Expression of Girdin in the Nucleus Indicates Worse Prognosis for Patients with Estrogen Receptor-Positive Breast Cancer
    Wen-Ting Peng
    Xin Hu
    Ling Yao
    Yi-Zhou Jiang
    Zhi-Ming Shao
    Annals of Surgical Oncology, 2014, 21 : 648 - 656
  • [28] HER2 and hormone receptor-positive breast cancer—blocking the right target
    Javier Cortés
    Cristina Saura
    Meritxell Bellet
    Eva Muñoz-Couselo
    Natalia Ramírez-Merino
    Virginia Calvo
    Jose Pérez
    María Vidal
    Nature Reviews Clinical Oncology, 2011, 8 : 307 - 311
  • [29] Elevated Expression of Girdin in the Nucleus Indicates Worse Prognosis for Patients with Estrogen Receptor-Positive Breast Cancer
    Peng, Wen-Ting
    Hu, Xin
    Yao, Ling
    Jiang, Yi-Zhou
    Shao, Zhi-Ming
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S648 - S656
  • [30] Prognostic significance of estrogen receptor in hormone receptor-positive and HER2-positive breast cancer
    Hikichi, M.
    Ushimado, K.
    Ri, Y.
    Kobayashi, N.
    Utsumi, T.
    BREAST, 2017, 32 : S94 - S95
12345